Cancer3.AIAI in OncologyDatasets › TCGA — The Cancer Genome Atlas (via NCI Genomic Data Commons)
Registry / portal Free registration NIH GDS Policy — open tier; controlled tier via dbGaP

TCGA — The Cancer Genome Atlas (via NCI Genomic Data Commons)

The reference multi-omics cancer cohort: molecular profiles, clinical outcomes and whole-slide images for 33 cancer types, downloadable through the GDC portal and API.

At a glance

ProviderNCI / NHGRI; hosted by the Genomic Data Commons
AccessFree registration
LicenceNIH GDS Policy — open tier; controlled tier via dbGaP
patients11 000
diagnostic + tissue WSIs30 000
Size notes33 cancer types; ~11,000 patients with molecular data; diagnostic slides for most cases; matched clinical follow-up
FormatsSVS, MAF, VCF, BAM, TSV, JSON

Labels and annotations

Per-case clinical data (stage, grade, vital status, survival), somatic mutations (MAF), copy number, RNA-seq expression, methylation, miRNA, and slide images; slide-level labels are the pathology diagnosis, not region annotations.

Details

What is in it

  • Harmonised genomic data re-processed by the GDC against GRCh38.
  • Diagnostic (FFPE) and frozen-tissue slides in Aperio SVS format.
  • Clinical and biospecimen supplements; cBioPortal offers a browsing front end.

How to get it

  • Open-access files download without an account through the portal or the gdc-client.
  • Controlled data require dbGaP authorisation via an institutional signing official.

Known pitfalls

  • Slide scanners, sites and batch effects vary; several pathology foundation models pretrained on TCGA, so it is not an external test set for them.
  • Survival follow-up is short for some projects.

Models trained or evaluated on it

  • evaluation UNI Mahmood Lab, Brigham and Women's Hospital / Harvard Medical School — subtyping and biomarker tasks drawn from TCGA cohorts
  • evaluation CONCH Mahmood Lab, Brigham and Women's Hospital / Harvard Medical School
  • evaluation Prov-GigaPath Microsoft Research / Providence Health / University of Washington
  • pretraining Phikon-v2 Owkin — part of PANCAN-XL — not a valid external test set
  • training CHIEF Yu Lab, Harvard Medical School
  • evaluation H-optimus-0 Bioptimus
  • training Phikon-v2 Owkin

Sources

  1. GDC Data Portal
  2. NCI — The Cancer Genome Atlas Program

This page is educational — it is not medical advice and does not replace consultation with an oncologist. Diagnostic and treatment decisions are made solely by specialist physicians.